MAZE (Maze Tx) Total Business Assets

MAZE (Maze Therapeutics, Inc.) - company brandmark

Maze Therapeutics Inc (MAZE) relies on proprietary gene-modifying discovery methods, which eliminates non-core competitors before the conclusion of initial trials. The business strategy is based on partnerships with behemoths such as GSK to combat orphan diseases. This chart of the stock's total assets, valued at 417.60, complements the analysis. Position protection is guaranteed by the unique Compass system and strict FDA oversight.

MAZE - Maze Therapeutics Inc Company Total Assets over the range 02/01/2025 - 10/31/2026

Financial and market metric breakdowns for Maze Tx (MAZE)

- stock value and consensus price forecast:
Market Price mazetx.com|MAZE - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Maze Therapeutics Corp|MAZE - Total Company Value
- book capitalization information:
Equity per Share Maze Therapeutics|MAZE - Book Capitalization|Market Capitalization to Book Value Ratio mazetx.com|MAZE - Aggregate Company Assets
- debt and liquidity details:
Total Debt to Equity Ratio Maze Therapeutics Inc|MAZE - Long-Term Debt to Capital|Short-Term Debt to Capital Maze Therapeutics Corp|MAZE - Company Total Debt|Debts to Book Capitalization Ratio Maze Therapeutics Corp|MAZE - Company Long-Term Debts|Short-Term Debt Maze Therapeutics|Intermediate Coverage Ratio mazetx.com
- earnings and market ratios statistics:
MAZE - Net Income
Summary company analysis:mazetx.com MAZE
Core merchandise of Maze Tx

This indicator reflects the total value of Maze Therapeutics Inc (MAZE) resources, calculated inversely via return on assets (ROA), allowing for the rapid tracking of shifting economic phases. The trend in consolidated assets for Maze Therapeutics Inc (MAZE) is critical when assessing cash burn and runway, as a shrinking asset base amid the development of Pompe disease therapy signals liquidity risk.

Direct competitors

Company Assets Tempus AI, Inc (TEM)|QGEN (Qiagen) - Company Total Assets|Total Business Assets IONS (Ionis Pharmaceuticals, Inc.)|Aggregate Company Assets Repligen Corp. (RGEN)|Avidity Corp - Total Business Assets|Company Total Assets CRSP (CRISPR Therapeutics AG)|Company Total Assets genedx.com WGS|RARE - Aggregate Company Assets|Beam Therapeutics Inc (BEAM) - Cumulative Company Assets|SRPT: Company Total Assets|Twist Bioscience Corp (TWST) - Company Total Assets|Cumulative Company Assets TXG|intelliatx.com - Total Asset Value of Company|Company Total Assets STOK|BLFS - Company Assets|Wave Life Sciences Corp - Cumulative Company Assets|Aggregate Asset Value SION|PRME: Cumulative Company Assets|tayshagtx.com - Aggregate Business Assets|QURE: Company Total Assets|MeiraGTx Holdings - Aggregate Asset Value|RGNX (Regenxbio) - Company Total Assets|Company Assets Solid Corp SLDB|Aggregate Company Assets Ocugen, Inc. (OCGN)|PACB (pacb.com) - Aggregate Asset Value|Company Total Assets BNTC (Benitec Biopharma)|Company Total Assets Design Therapeutics Inc DSGN|RCKT - Aggregate Company Assets|Total Asset Value of Company FDMT|LXEO: Company Total Assets|Company Assets Korro Bio (KRRO)|Cumulative Company Assets EDIT|Company Total Assets Silence Therapeutics PLC|Cumulative Company Assets PRQR (ProQR Therapeutics N.V.)|Aggregate Business Assets CDXS|Company Total Assets SGMO (Sangamo Therapeutics)|Company Total Asset Base Nautilus Biotechnology, Inc. (NAUT)|Metagenomi - Company Total Assets|precisionbiosciences.com (DTIL) - Cumulative Company Assets|generationbio.com (GBIO) - Aggregate Company Assets|BOLD - Company Total Asset Base|Cumulative Company Assets XCUR|IMNN: Aggregate Asset Value|Company Total Assets PHIO|Company Total Asset Base mustangbio.com|Aggregate Company Assets TransCode Therapeutics, Inc. RNAZ|BNGO: Total Business Assets|Applied DNA Sciences - Company Total Assets|bluebirdbio.com (BLUE) - Cumulative Company Assets|immunoprecise.com (IPA) - Aggregate Company Assets|Cumulative Company Assets Omega Therapeutics Inc|OMIC (Singular Genomics Systems Inc) - Company Total Assets|Company Total Assets Regulus|Cumulative Company Assets SYRS (Syros Pharmaceuticals)|TBIO: Total Asset Value of Company|Company Total Assets TCON (TRACON Pharmaceuticals, Inc.)|Unity Biotechnology Inc. (UBX) - Company Assets